Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis

Journal of Orthopaedic Research

Volumn 29, Issue 3, 2011, Pages 419-424

  Brennan, Orlaith ^a,b   Kennedy, Oran D ^a,b   Lee, T Clive ^a,b   Rackard, Susan M ^c   Obrien, Fergal J ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

apoptosis; bisphosphonate; microcrack; osteocyte; osteoporosis; ovine

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; ESTROGEN DEFICIENCY; EWE; FRACTURE; METACARPAL BONE; NONHUMAN; OSTEOCYTE; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; CELL SURVIVAL; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; IMIDAZOLES; OSTEOCYTES; OSTEOPOROSIS; OVARIECTOMY; SHEEP;

EID: 79251544283     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21229     Document Type: Article

References (55)

1. Bonewald LF,. 2004. Osteocyte biology: Its implications for osteoporosis. J Musculoskelet Neuronal Interact 4: 101-104.
2. Hazenberg JG, Taylor D, Lee TC,. 2007. The role of osteocytes and bone microstructure in preventing osteoporotic fractures. Osteoporos Int 18: 1-8.
3. Gu G, Hentunen TA, Nars M, et al. 2005. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis 10: 583-595.
4. Huber C, Collishaw S, Mosley JR, et al. 2007. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: Implications for bone quality maintenance. Calcif Tissue Int 81: 139-144.
5. Mann V, Huber C, Kogianni G, et al. 2007. The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro. Bone 40: 674-684.
6. Power J, Noble BS, Loveridge N, et al. 2001. Osteocyte lacunar occupancy in the femoral neck cortex: An association with cortical remodeling in hip fracture cases and controls. Calcif Tissue Int 69: 13-19.
7. Verborgt O, Gibson GJ, Schaffler MB,. 2000. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15: 60-67.
8. Burr DBFM, Fyhrie DP, Martin RB, et al. 1997. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 12 (1) 6-15.
9. Parfitt AM,. 2002. Life history of osteocytes: Relationship to bone age, bone remodeling, and bone fragility. J Musculoskelet Neuronal Interact 2: 499-500.
10. Herd RJ, Balena R, Blake GM, et al. 1997. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: A 2-year, double-blind, placebo-controlled study. Am J Med 103: 92-99.
11. Meunier PJ, Confavreux E, Tupinon I, et al. 1997. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up). J Clin Endocrinol Metab 82: 2784-2791.
12. Pouilles JM, Tremollieres F, Roux C, et al. 1997. Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy. Osteoporos Int 7: 213-218.
13. Sparidans RW, Twiss IM, Talbot S,. 1998. Bisphosphonates in bone diseases. Pharm World Sci 20: 206-213.
14. Inui K, Takaoka K,. 2003. Etidronate. Nippon Rinsho 61: 226-230.
15. Black DM, Cummings SR, Karpf DB, et al. 1996. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348: 1535-1541.
16. Reid IR, Brown JP, Burckhardt P, et al. 2002. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346: 653-661.
17. Hornby SB, Evans GP, Hornby SL, et al. 2003. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 72: 519-527.
18. Glatt M, Pataki A, Evans GP, et al. 2004. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid. Osteoporos Int 15: 707-715.
19. Rodan GA, Reszka AA,. 2002. Bisphosphonate mechanism of action. Curr Mol Med 2: 571-577.
20. Plotkin LI, Weinstein RS, Parfitt AM, et al. 1999. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104: 1363-1374.
21. Benford HL, McGowan NW, Helfrich MH, et al. 2001. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28: 465-473.
22. Chapurlat RD, Delmas PD,. 2006. Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2: 211-219.
23. Follet H, Li J, Phipps RJ, et al. 2007. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone 40: 1172-1177.
24. Komatsubara S, Mori S, Mashiba T, et al. 2003. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18: 512-520.
25. Komatsubara S, Mori S, Mashiba T, et al. 2004. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 19: 999-1005.
26. Mashiba T, Hirano T, Turner CH, et al. 2000. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15: 613-620.
27. Mashiba T, Turner CH, Hirano T, et al. 2001. Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures. Bone 29: 271-278.
28. Lee TC, Mohsin S, Taylor D, et al. 2003. Detecting microdamage in bone. J Anat 203: 161-172.
29. Turner AS, Mallinckrodt CH, Alvis MR, et al. 1995. Dose-response effects of estradiol implants on bone mineral density in ovariectomized ewes. Bone 17: 421S-427S.
30. Newman E, Turner AS, Wark JD,. 1995. The potential of sheep for the study of osteopenia: Current status and comparison with other animal models. Bone 16: 277S-284S.
31. Liebschner MA,. 2004. Biomechanical considerations of animal models used in tissue engineering of bone. Biomaterials 25: 1697-1714.
32. Kennedy OD, Brennan O, Rackard SM, et al. 2009. Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res 27: 303-309.
33. Kennedy OD, Brennan O, Mauer P, et al. 2008. The effects of increased intracortical remodeling on microcrack behaviour in compact bone. Bone 43: 889-893.
34. Boonen S, Black DM, Colon-Emeric CS, et al. 2010. Efficacy and safety of a once-yearly intravenous zoledronic acid 5mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58: 292-299.
35. Hoff AO, Toth BB, Altundag K, et al. 2008. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23: 826-836.
36. Metz LN, Martin RB, Turner AS,. 2003. Histomorphometric analysis of the effects of osteocyte density on osteonal morphology and remodeling. Bone 33: 753-759.
37. Tomkinson A, Gevers EF, Wit JM, et al. 1998. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13: 1243-1250.
38. Lee TC, Staines A, Taylor D,. 2002. Bone adaptation to load: Microdamage as a stimulus for bone remodelling. J Anat 201: 437-446.
39. Burr DB, Turner CH, Naick P, et al. 1998. Does microdamage accumulation affect the mechanical properties of bone? J Biomech 31: 337-345.
40. Donahue SW, Sharkey NA, Modanlou KA, et al. 2000. Bone strain and microcracks at stress fracture sites in human metatarsals. Bone 27: 827-833.
41. Schaffler MB, Choi K, Milgrom C,. 1995. Aging and matrix microdamage accumulation in human compact bone. Bone 17: 521-525.
42. Healy C, Kennedy OD, Brennan O, et al. 2010. Structural adaptation and intracortical bone turnover in an ovine model of osteoporosis. J Orthop Res 28 (2): 248-251.
43. Allen MR, Iwata K, Phipps R, et al. 2006. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39: 872-879.
44. Forwood MR, Burr DB, Takano Y, et al. 1995. Risedronate treatment does not increase microdamage in the canine femoral neck. Bone 16: 643-650.
45. Martin RB, Burr DB,. 1982. A hypothetical mechanism for the stimulation of osteonal remodelling by fatigue damage. J Biomech 15: 137-139.
46. Mohsin S, OBrien FJ, Lee TC,. 2006. Osteonal crack barriers in ovine compact bone. J Anat 208: 81-89.
47. Mohsin S, OBrien FJ, Lee TC,. 2006. Microcracks in compact bone: A three-dimensional view. J Anat 209: 119-124.
48. OBrien FJ, Taylor D, Clive Lee T,. 2005. The effect of bone microstructure on the initiation and growth of microcracks. J Orthop Res 23: 475-480.
49. Wasserman N, Yerramshetty J, Akkus O,. 2005. Microcracks colocalize within highly mineralized regions of cortical bone tissue. Eur J Morphol 42: 43-51.
50. Boyce TM, Fyhrie DP, Glotkowski MC, et al. 1998. Damage type and strain mode associations in human compact bone bending fatigue. J Ortho Res 16: 322-329.
51. OBrien FJ, Hardiman DA, Hazenberg JG, et al. 2005. The behaviour of microcracks in compact bone. Eur J Morphol 42: 71-79.
52. OBrien FJ, Taylor D, Lee TC,. 2002. An improved labelling technique for monitoring microcrack growth in compact bone. J Biomech 35: 523-526.
53. OBrien FJ, Taylor D, Lee TC,. 2003. Microcrack accumulation at different intervals during fatigue testing of compact bone. J Biomech 36: 973-980.
54. Fazzalari NL, Forwood MR, Manthey BA, et al. 1998. Three-dimensional confocal images of microdamage in cancellous bone. Bone 23: 373-378.
55. OBrien FJ, Taylor D, Dickson GR, et al. 2000. Visualisation of three-dimensional microcracks in compact bone. J Anat 197 (Pt 3): 413-420.